Research Unit of Oncology, The Academy of Geriatric Cancer Research (www.agecare.org), Odense University Hospital, Sdr. Boulevard 29, 5000, Odense C, Denmark; Family Focused Healthcare Research Center (FaCe), Denmark; Department of Clinical Research, University of Southern Denmark, J.B. Winsløws Vej 19.3, DK-5000 Odense C, Denmark.
Research Unit of Oncology, The Academy of Geriatric Cancer Research (www.agecare.org), Odense University Hospital, Sdr. Boulevard 29, 5000, Odense C, Denmark; Family Focused Healthcare Research Center (FaCe), Denmark; Department of Clinical Research, University of Southern Denmark, J.B. Winsløws Vej 19.3, DK-5000 Odense C, Denmark.
Eur J Oncol Nurs. 2021 Jun;52:101958. doi: 10.1016/j.ejon.2021.101958. Epub 2021 Apr 18.
This study investigated experiences and levels of distress and resilience of Danish cancer patients during the second wave of the COVID-19 pandemic.
The mixed methods design included a subset of cancer patients who responded to a cross-sectional survey in May 2020. Data were collected through telephone interviews. The National Comprehensive Cancer Network Distress Thermometer (NCCN DT), and Connor-Davidson-Resilience Scale (CD-RISC2) were used to measure distress and resilience. Data were analysed by thematic analysis and descriptive statistics.
Forty patients with lung, breast, colorectal and skin (melanoma) cancer were included; 65% were women. Mean age was 62.2 years (standard deviation [SD], 13.2). Most patients had curable disease (65%); 50% were in treatment and 50% in post-treatment follow up. The interviews revealed four themes: 1) the cost of living with cancer during COVID-19, 2) changes in cancer care delivery, 3) particularly vulnerable, and 4) importance of family support. Mean NCCN DT score was 2.3 (SD, 2.6) while the mean CD-RISC2 score was 7.25 (SD, 1.1).
Despite drastic changes in daily life imposed by COVID-19 restrictions, Danish cancer patients had remarkably low levels of distress and high levels of resilience. Patients in active treatment, with comorbidities or elderly felt vulnerable. Family support was invaluable in critical times.
本研究调查了丹麦癌症患者在 COVID-19 大流行第二波期间的经历、困扰程度和适应能力。
混合方法设计包括对 2020 年 5 月参与横断面调查的癌症患者的一个子样本。通过电话访谈收集数据。采用国家综合癌症网络困扰温度计（NCCN DT）和康纳-戴维森适应量表（CD-RISC2）来衡量困扰和适应能力。采用主题分析和描述性统计对数据进行分析。
共纳入 40 例肺癌、乳腺癌、结直肠癌和皮肤（黑色素瘤）癌症患者；65%为女性。平均年龄为 62.2 岁（标准差 [SD]，13.2）。大多数患者患有可治愈的疾病（65%）；50%处于治疗中，50%处于治疗后随访中。访谈揭示了四个主题：1）COVID-19 期间癌症患者的生活成本，2）癌症护理提供方式的变化，3）特别脆弱，4）家庭支持的重要性。NCCN DT 评分的平均值为 2.3（SD，2.6），而 CD-RISC2 评分的平均值为 7.25（SD，1.1）。
尽管 COVID-19 限制措施对日常生活造成了巨大变化，但丹麦癌症患者的困扰程度明显较低，适应能力较强。处于积极治疗中、合并症或老年患者感到脆弱。在关键时刻，家庭支持是非常宝贵的。
